Prognostic scoring systems in SM
| Parameter . | REMA (for ISM) . | MAPS . | IPSM . | MARS . | GPS . | |||
|---|---|---|---|---|---|---|---|---|
| OS . | PFS . | Nonadvanced . | Advanced . | OS . | PFS . | |||
| WHO (advSM) | + | |||||||
| Age ≥60 y | + | + | + | + | ||||
| Anemia, g/dL | ||||||||
| ≤10 | + | |||||||
| ≤11 | + | + | ||||||
| Thrombocytopenia, × 109/L | ||||||||
| <100 | + | + | + | |||||
| <150 | + | |||||||
| Leukocytosis, × 109/L | ||||||||
| ≥16 | + | |||||||
| Increased serum markers | ||||||||
| Baseline serum tryptase | + | + | ||||||
| β2-microglobulin | + | + | ||||||
| Alkaline phosphatase | + | + | + | |||||
| Genetics | ||||||||
| BM KIT D816V VAF ≥1% | + | |||||||
| Additional somatic mutations | + (A/R/D) | + (A/R/D) | + (A/R/NRAS) | + (S/A/R) | + (S/A/R/D) | |||
| Parameter . | REMA (for ISM) . | MAPS . | IPSM . | MARS . | GPS . | |||
|---|---|---|---|---|---|---|---|---|
| OS . | PFS . | Nonadvanced . | Advanced . | OS . | PFS . | |||
| WHO (advSM) | + | |||||||
| Age ≥60 y | + | + | + | + | ||||
| Anemia, g/dL | ||||||||
| ≤10 | + | |||||||
| ≤11 | + | + | ||||||
| Thrombocytopenia, × 109/L | ||||||||
| <100 | + | + | + | |||||
| <150 | + | |||||||
| Leukocytosis, × 109/L | ||||||||
| ≥16 | + | |||||||
| Increased serum markers | ||||||||
| Baseline serum tryptase | + | + | ||||||
| β2-microglobulin | + | + | ||||||
| Alkaline phosphatase | + | + | + | |||||
| Genetics | ||||||||
| BM KIT D816V VAF ≥1% | + | |||||||
| Additional somatic mutations | + (A/R/D) | + (A/R/D) | + (A/R/NRAS) | + (S/A/R) | + (S/A/R/D) | |||
Adapted from Muñoz-González and Orfao85 with permission.
A, ASXL1; D, DNMT3A; GPS, global prognostic scoring system; R, RUNX1; S, SRSF2.